• Markets
    • icon
  • Companies
SIG · ASX

Sigma Healthcare Ltd (ASX:SIG)

AU$0.72

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
Hammer Bullish HALO Small HALO Ords GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

SIG Overview

SIG Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About SIG

Website

Sigma Healthcare Ltd

Telephone

61.03.9215.9215

Address

Level 6 2125 Dandenong Road Clayton, Victoria (VIC) 3168

Description

Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The firm's activities include wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies, including the provision of retail support services to the branded network of pharmacy members, dose administration aid services, technology and data analytics solutions to the customers. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.

SIG Price Chart

Key Stats

Market Cap

AU$741.49M

PE

72.10

EV/EBITDA

15.8

Dividends Overview

DIV Yield

2.0%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.55 - 0.88

Trade Value (12mth)

AU$342,712.00

1 week

2.14%

1 month

7.52%

YTD

18.18%

1 year

14.4%

All time high

2.1614

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

1021m

HALO Sector

Healthcare

Next Company Report Date

21-Mar-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.05

SIG Announcements

Latest Announcements

Date Announcements

31 March 17

Sigma Pharmaceuticals Limited - Notice of Annual General Meeting/Proxy Form (SIP-AU)

×

Sigma Pharmaceuticals Limited - Notice of Annual General Meeting/Proxy Form (SIP-AU)

31 March 10

Full Year Results Presentation (SIP-AU)

×

Full Year Results Presentation (SIP-AU)

31 August 23

Chemist Warehouse Supply Agreement signed

×

Chemist Warehouse Supply Agreement signed

30 June 22

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

30 June 22

Change in substantial holding from MQG

×

Change in substantial holding from MQG

30 June 22

Change in substantial holding

×

Change in substantial holding

30 June 22

Change in substantial holding - HMC Capital Partners

×

Change in substantial holding - HMC Capital Partners

30 December 22

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 September 10

Sigma 2010 Half Year Results Presentation (SIP-AU)

×

Sigma 2010 Half Year Results Presentation (SIP-AU)

29 November 22

Sigma secures refinancing of Debt facility

×

Sigma secures refinancing of Debt facility

29 November 11

Sigma Pharmaceuticals Limited - Investor Update Presentation (SIP-AU)

×

Sigma Pharmaceuticals Limited - Investor Update Presentation (SIP-AU)

29 March 22

Appendix 4E & Full Year Financial Report

×

Appendix 4E & Full Year Financial Report

29 March 22

Sigma Full Year 2021/2022 ASX Release

×

Sigma Full Year 2021/2022 ASX Release

29 March 22

Sigma Full Year 2021/22 Results Presentation

×

Sigma Full Year 2021/22 Results Presentation

29 March 22

Dividend/Distribution - SIG

×

Dividend/Distribution - SIG

29 March 11

Amendment to Results Presentation (SIP-AU)

×

Amendment to Results Presentation (SIP-AU)

29 December 21

Appendix 3Y Change of Directors Interest notices

×

Appendix 3Y Change of Directors Interest notices

28 March 11

Sigma Pharmaceuticals Limited - Results Presentation for the full year ended 31 January 2011 (SIP-AU)

×

Sigma Pharmaceuticals Limited - Results Presentation for the full year ended 31 January 2011 (SIP-AU)

28 June 22

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

28 June 22

Ceasing to be a substantial holder from CBA

×

Ceasing to be a substantial holder from CBA

27 March 14

Sigma Pharmaceuticals Limited - Sigma 2013/14 Full Year Results Presentation (SIP-AU)

×

Sigma Pharmaceuticals Limited - Sigma 2013/14 Full Year Results Presentation (SIP-AU)

27 June 22

Notice of initial substantial holder - HMC Capital Partners

×

Notice of initial substantial holder - HMC Capital Partners

27 June 22

Change in substantial holding

×

Change in substantial holding

27 June 22

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

27 July 23

Appointment of CFO

×

Appointment of CFO

26 September 22

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

26 September 22

Half Year Results

×

Half Year Results

SIG Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.04 -0.01 N/A Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.04 -0.01 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 450.0 -116.6 N/A Lock Lock Lock
     PE X Lock Lock Lock Lock 23.7 0.0 72.1 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 10.4 7.0 15.8 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.05 0.03 N/A Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.08 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 167.4 -41.9 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock -9.6 -18.1 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.02 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 0.0 100.0 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.9 4.3 2.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 23 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.52 0.49 N/A Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.39 0.36 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.7 -6.9 N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,018 988 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 986 988 N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 3,400 3,446 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.8 1.3 N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 309 310 N/A Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 211 199 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.2 -5.3 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.2 5.8 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 94 94 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -70 -82 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.3 -18.2 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.1 -2.4 N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 29 28 N/A Lock Lock Lock
EBIT $m Lock Lock Lock Lock -98 -110 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.6 -12.0 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.9 -3.2 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 29 -8 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -16 -2 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock 44 -7 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 453.0 -116.6 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 1.3 -0.2 N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 -46 N/A Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 51 14 N/A Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 124 -17 N/A Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -266 129 N/A Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -65 -60 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -145.0 6.3 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 -0.0 N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 7 5 N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 16 31 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 1,219 1,275 N/A Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 140 298 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 199 292 N/A Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 705 787 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 514 487 N/A Lock Lock Lock
Invested Capital Lock Lock Lock Lock 653 785 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 3.2 20.1 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.6 -0.6 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 8.5 -1.5 N/A Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -13.5 -14.1 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 6.7 -1.0 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -2.0 -6.3 N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -5.9 -7.6 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.9 -3.5 N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 38.8 60.0 N/A Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.3 1.7 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.7 1.0 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 2.3 4.1 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -2.5 -10.1 N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 10.4 10.0 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 9.1 9.7 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 19.0 11.3 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 10.7 10.2 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 2.8 2.7 N/A Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 2.8 2.7 N/A Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.8 -0.2 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.3 -0.7 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -57.6 N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.6 -0.6 N/A Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.4 2.6 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 8.5 -1.5 N/A Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 77.3 374.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 6.6 -5.6 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 40.0 37.7 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 35.1 36.3 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 75.1 74.0 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 41.8 40.7 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 33.3 33.3 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

2.0%

Franking Level

100%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.05%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

SIG Shortsell

Frequently Asked Questions

The current share price of Sigma Healthcare Ltd (SIG:ASX) is AU$0.72.
The 52-week high share price for Sigma Healthcare Ltd (SIG:ASX) is AU$0.88.
The 52-week low share price for Sigma Healthcare Ltd (SIG:ASX)? is AU$0.55.
The current TTM dividend payout for Sigma Healthcare Ltd (SIG:ASX) is 2.00.
The last dividend payment of Sigma Healthcare Ltd (SIG:ASX) is AU$0.01.
Sigma Healthcare Ltd (SIG:ASX) has a franking level of 100%.
Sigma Healthcare Ltd (SIG:ASX) is classified in the Healthcare.
The current P/E ratio for Sigma Healthcare Ltd (SIG:ASX) is 72.10.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.